INS and sarcopenia: In conclusion, administration of metformin for six months had favorable effects on body composition, insulin sensitivity, and glucose homeostasis in adults with newly diagnosed type 2 diabetes and subsequently was expected to postpone the incidence of sarcopenia especially in women with type 2 diabetes who are at higher risk for loss of skeletal muscle mass.